Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas.

Cervical cancer screening involves HPV and PAP tests, which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented.

Impact of Covid-19 on the Global HPV Testing and PAP Test Market

Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact on the global market during Covid outbreak.

However, in April 2020, amongst the Covid pandemic when all non-emergence procedures stopped, in Sweden HPV sampling kits were distributed among the eligible group of women.

Technological Developments in the HPV Testing and PAP Test Market

Rising demand for the development of advanced screening tests for the early detection of cervical and vaginal cancers is slated to trigger the growth of the HPV testing and PAP test market. The surge in the number of screening campaigns undertaken by the government and non-government companies is another major factor driving the market's growth across the globe.

“When everything came to a halt, we had to think of something totally different. The expectation is that many women will be prevented from developing cervical cancer and we will progress faster on the path to reaching the WHO target of elimination of cervical cancer with the help of these kits.”-Cancer Specialist, Research-Led Medical University, Sweden

An Increasing Cases of Cervical Cancer Triggers the Growth of the Global HPV Testing and PAP Test Market

Rising number of cases of cervical cancers, growing aging population and the rapid development of advanced screening tests are some of the major factors driving the growth of the global market. Public awareness campaigns undertaken by the government and other companies, enriching health insurance coverage, and favourable reimbursement policies are some of the other prime factors driving the demand of the HPV Testing and PAP Test market. 

Key Market Challenges: Global HPV Testing and PAP Test Market

Adoption of revised regulatory policies for cervical cancer screening, availability of HPV vaccination globally, and an increasing costs of screening tests in developing regions may affect the growth of the global HPV Testing and PAP Test market in the coming years.

North America Holds the Largest Market Share in the Global HPV Testing and PAP Test Market 

North America is poised to hold the largest market share in the global HPV Testing and PAP Test market. This can be mainly attributed due to the rising number of cervical cancers, positive reimbursement policies and the presence of leading market players and fully-developed healthcare infrastructures in North America. 

However, the APAC region is slated to grow with a highest CAGR during the forecast period. Major factors such as technological developments, free screening programs, and favourable initiatives undertaken by public and private companies are some of the chief factors driving the growth of the APAC market.

Competitive Landscape Analysis: HPV Testing and PAP Test Market

Some of the leading players operating in the global HPV Testing and PAP test market are as follows: -

• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Becton, Dickinson and Company
• Quest Diagnostics
• Hologic Inc.
• Femasys Inc.
• Arbor Vita Corporation
• Seegene Inc.
• Thermo Fischer Scientific

The global HPV Testing and PAP test market is a growing market and is set to witness a healthy growth in the coming years due growing awareness for early diagnosis of cervical cancer, increasing investments in R&D activities to introduce advanced screening tests, and aggressive growth strategies adopted by the leading market players.

Get Detailed Insights on HPV Testing and PAP Test Market with a FREE Sample Report @ https://meditechinsights.com/hpv-testing-and-pap-test-market/